JP2010538009A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538009A5
JP2010538009A5 JP2010523135A JP2010523135A JP2010538009A5 JP 2010538009 A5 JP2010538009 A5 JP 2010538009A5 JP 2010523135 A JP2010523135 A JP 2010523135A JP 2010523135 A JP2010523135 A JP 2010523135A JP 2010538009 A5 JP2010538009 A5 JP 2010538009A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
effective amount
active ingredient
compound according
airway disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010523135A
Other languages
English (en)
Japanese (ja)
Other versions
JP5529740B2 (ja
JP2010538009A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/074643 external-priority patent/WO2009029717A1/en
Publication of JP2010538009A publication Critical patent/JP2010538009A/ja
Publication of JP2010538009A5 publication Critical patent/JP2010538009A5/ja
Application granted granted Critical
Publication of JP5529740B2 publication Critical patent/JP5529740B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010523135A 2007-08-28 2008-08-28 カルバメート立体異性体 Expired - Fee Related JP5529740B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96639107P 2007-08-28 2007-08-28
US60/966,391 2007-08-28
PCT/US2008/074643 WO2009029717A1 (en) 2007-08-28 2008-08-28 Carbamate stereoisomer

Publications (3)

Publication Number Publication Date
JP2010538009A JP2010538009A (ja) 2010-12-09
JP2010538009A5 true JP2010538009A5 (enExample) 2011-10-13
JP5529740B2 JP5529740B2 (ja) 2014-06-25

Family

ID=39967298

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523135A Expired - Fee Related JP5529740B2 (ja) 2007-08-28 2008-08-28 カルバメート立体異性体

Country Status (12)

Country Link
US (2) US7718822B2 (enExample)
EP (1) EP2190813B1 (enExample)
JP (1) JP5529740B2 (enExample)
KR (1) KR20100065303A (enExample)
AR (1) AR071045A1 (enExample)
AU (1) AU2008293444B2 (enExample)
CA (1) CA2696922C (enExample)
ES (1) ES2430338T3 (enExample)
MX (1) MX2010002039A (enExample)
NZ (1) NZ583202A (enExample)
TW (1) TWI465416B (enExample)
WO (1) WO2009029717A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501994B2 (en) * 2007-08-28 2013-08-06 Sunovion Pharmaceuticals Inc. Acetamide stereoisomer
US7718822B2 (en) * 2007-08-28 2010-05-18 Sepracor Inc. Carbamate Stereoisomer
CN112279776B (zh) * 2020-11-02 2022-09-02 扬州中宝药业股份有限公司 一种合成阿福特罗游离碱的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657319A (en) * 1970-05-05 1972-04-18 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-carboalkoxyaminobenzyl alcohols
DE2115926C3 (de) * 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
DE2366625C2 (enExample) 1972-02-05 1988-06-09 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
GB1415256A (en) 1972-02-05 1975-11-26 Yamanouchi Pharma Co Ltd Alpha-aminomethylbenzyl alcohol derivatives
JPS4880523A (enExample) * 1972-02-05 1973-10-29
JPS599542B2 (ja) * 1980-06-11 1984-03-03 山之内製薬株式会社 新規な3−アシルアミノ−4−ヒドロキシ−α−(アラルキルアミノメチル)ベンジルアルコ−ルの製法
ES2005492A6 (es) 1987-12-23 1989-03-01 Lasa Lab Procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2((2- (4-metoxifenil)-1metiletil)amino)etil)fenil)foramida (i).
ES2031407A6 (es) 1988-10-05 1992-12-01 Lasa Lab Mejoras introducidas en el objeto de la patente principal n{ 8703715 por: procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2-((2-(4-metoxifenil)-1-metiletil)amino)etil)fenil)formamida".
CA2242351C (en) 1996-01-10 2003-03-11 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same
PT938467E (pt) * 1996-11-11 2002-11-29 Sepracor Inc Processo para a preparacao de isomeros opticamente puros de formoterol
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
JP2003525090A (ja) * 2000-03-01 2003-08-26 グラクソ グループ リミテッド 定量噴霧式吸入器
US6472563B1 (en) * 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
US7718822B2 (en) * 2007-08-28 2010-05-18 Sepracor Inc. Carbamate Stereoisomer

Similar Documents

Publication Publication Date Title
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
RU2017127135A (ru) Терапевтическое средство против рака желчных протоков
JP2009502743A5 (enExample)
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
NO20083863L (no) Pyrazoler som 11-beta-hsd-1
JP2012512907A5 (enExample)
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
NO20092033L (no) Nye forbindelser
MX2012004420A (es) Compuestos de espiropiperidino y uso farmaceutico de los mismos para tratar diabetes.
BRPI0906104A2 (pt) "derivado de ácido nuclêico peptídico, composição farmacêutica contendo uma quantidade "terapeuticamente eficaz do derivado de ácido nuclêico peptídico, composição farmacêutica contendo uma quantidade terapeuticamente eficaz do derivado de ácido nuclêico peptídico,método de utilização do derivado de ácido nuclêico peptídico e composto"
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
MA32787B1 (fr) Peptides antiviraux therapeutiques
CN103717571B8 (zh) 9‑氨基甲基取代的四环素类化合物
BR112014009910A2 (pt) formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico
EP1894235A4 (en) METHOD FOR PRODUCING AN ELECTRODE
EP3020397A3 (en) Process for the manufacture of ajoene derivatives
WO2008050199A8 (en) Substituted phenylmethyl bicyclocarboxyamide compounds
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
NZ630488A (en) Piperidine derivatives for gpr119 agonist
WO2008003155A3 (en) Methods to prepare penta-1,4-dien-3-ones and substituted cyclohexanones and derivatives with antitumoral and antiparasitic properties, the compounds and their uses
EP2077846A4 (en) BENZOXAZEPINE COMPOUNDS, PREPARATION THEREOF AND USE THEREOF
NO20063516L (no) Ny krystallinsk form III av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
BR112012012755A2 (pt) "composto de fórmula (i), composição fungicida e método para controle do fungo fitopatogênico de culturas"